85 related articles for article (PubMed ID: 6153225)
1. Routine pulmonary function tests during bleomycin therapy. Tests may be ineffective and potentially misleading.
Lewis BM; Izbicki R
JAMA; 1980 Jan; 243(4):347-51. PubMed ID: 6153225
[TBL] [Abstract][Full Text] [Related]
2. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.
Comis RL; Kuppinger MS; Ginsberg SJ; Crooke ST; Gilbert R; Auchincloss JH; Prestayko AW
Cancer Res; 1979 Dec; 39(12):5076-80. PubMed ID: 91430
[TBL] [Abstract][Full Text] [Related]
3. Role of carbon monoxide diffusing capacity in the early detection of major bleomycin-induced pulmonary toxicity.
Bell MR; Meredith DJ; Gill PG
Aust N Z J Med; 1985 Apr; 15(2):235-40. PubMed ID: 2411250
[TBL] [Abstract][Full Text] [Related]
4. Bleomycin-induced changes in the carbon monoxide transfer factor of the lungs and its components.
Luursema PB; Star-Kroesen MA; van der Mark TW; Sleyfer DT; Koops HS; Peset R
Am Rev Respir Dis; 1983 Nov; 128(5):880-3. PubMed ID: 6195947
[TBL] [Abstract][Full Text] [Related]
5. Carbon monoxide diffusing capacity is a poor predictor of clinically significant bleomycin lung. New Zealand Clinical Oncology Group.
McKeage MJ; Evans BD; Atkinson C; Perez D; Forgeson GV; Dady PJ
J Clin Oncol; 1990 May; 8(5):779-83. PubMed ID: 1692088
[TBL] [Abstract][Full Text] [Related]
6. Carbon monoxide diffusing capacity: a reliable indicator of bleomycin-induced pulmonary toxicity.
Sørensen PG; Rossing N; Rørth M
Eur J Respir Dis; 1985 May; 66(5):333-40. PubMed ID: 2410287
[TBL] [Abstract][Full Text] [Related]
7. [Role of single-breath carbon monoxide-diffusing capacity in monitoring the bleomycin-induced lung toxicity in human].
Wang JL; Ma SQ; Zhang YJ; Han JN; Zhu YJ; Ma Y; Shen K; Li LY
Zhonghua Nei Ke Za Zhi; 2003 Oct; 42(10):709-12. PubMed ID: 14633466
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary function in children treated for rhabdomyosarcoma.
Kaplan E; Sklar C; Wilmott R; Michaels S; Ghavimi F
Med Pediatr Oncol; 1996 Aug; 27(2):79-84. PubMed ID: 8649324
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary fibrosis and bleomycin].
Roujeau J; Narcy P; Marsan C; Trotoux J
Sem Hop; 1973 Jun; 49(27):1989-94. PubMed ID: 4126893
[No Abstract] [Full Text] [Related]
10. Bleomycin-associated pulmonary fibrosis: rapidly fatal progression without chest radiotherapy.
Dee GJ; Austin JH; Mutter GL
J Surg Oncol; 1987 Jun; 35(2):135-8. PubMed ID: 2438515
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of exercise diffusion capacity test on diffuse pulmonary fibrosis].
Yuan Y; Luo Y; Zeng J; He T
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Jun; 27(2):185-8. PubMed ID: 9389039
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary fibrosis due to bleomycin].
Ranfaing J; Guillier M; Simon-Rigaud ML; Banzet ML; Ledoux A
Poumon Coeur; 1977; 33(2):117-22. PubMed ID: 70032
[TBL] [Abstract][Full Text] [Related]
13. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
Kharasch VS; Lipsitz S; Santis W; Hallowell JA; Goorin A
Med Pediatr Oncol; 1996 Aug; 27(2):85-91. PubMed ID: 8649325
[TBL] [Abstract][Full Text] [Related]
14. [Effects of curcumin on bleomycin-induced damages in pulmonary functions in rats].
Zhao CJ; Niu JZ; Wang JF; Zhou G; Tang BH
Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1434-8. PubMed ID: 18837350
[TBL] [Abstract][Full Text] [Related]
15. [Changes in pulmonary function in SARS patients during the three-year convalescent period].
Liu YX; Ye YP; Zhang P; Chen J; Ye H; He YH; Li N
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):536-8. PubMed ID: 17767822
[TBL] [Abstract][Full Text] [Related]
16. Effect of low hemoglobin levels on the diffusing capacity of the lungs for CO. Investigations in persons with healthy lungs and in patients with interstitial pulmonary fibrosis.
Petermann W
Respiration; 1985; 47(1):30-8. PubMed ID: 3975492
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.
Wells AU; Desai SR; Rubens MB; Goh NS; Cramer D; Nicholson AG; Colby TV; du Bois RM; Hansell DM
Am J Respir Crit Care Med; 2003 Apr; 167(7):962-9. PubMed ID: 12663338
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary function in infiltrative lung disease.
Boushy SF; North LB
Chest; 1973 Oct; 64(4):448-53. PubMed ID: 4126537
[No Abstract] [Full Text] [Related]
19. Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis.
Nagao S; Taguchi K; Sakai H; Tanaka R; Horinouchi H; Watanabe H; Kobayashi K; Otagiri M; Maruyama T
Biomaterials; 2014 Aug; 35(24):6553-62. PubMed ID: 24811261
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
